Cold, Allergy, and Sinus Tablet Market Size | COVID-19 Impact Analysis | Forecast to 2027
The global cold, allergy, and
sinus tablet market is anticipated to grow at a significant CAGR during the
forecast period (2021-2027). The factors such as rising demand for over-the-counter
(OTC) medicines, as well as increasing air pollution, and the increasing
pharmaceutical R&D spending, is driving the growth of the market.
Additionally, the market is growing owing to the rising prevalence of asthma
and the growing geriatric population.
Moreover, the market is also
growing due to the COVID-19 pandemic, which increased the demand and sales of
OTC drugs for the management of common symptoms such as cough, cold, flu,
rhinitis. Apart from this, North America is expected to hold a prominent share
in the market owing to the presence of well established pharmaceutical brands
that have a strong brand image. Furthermore, the market is growing due to FDA
approvals. For instance, in March 2021, Merck announced the acceptance of a New
Drug Application (NDA) for gefapixant from the US Food and Drug Administration
(FDA). It is an orally administered, selective P2X3 receptor antagonist used
for the treatment of refractory chronic cough (RCC) or unexplained chronic
cough (UCC) in adults.
To Request a Sample of our Report on Cold, Allergy, and
Sinus Tablet Market: https://www.omrglobal.com/request-sample/cold-allergy-and-sinus-tablet-market
Some major players in the market include Merck & Co.,
Inc., Bayer AG, and Novartis International AG, among others. The market players
are contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical
expansion, partnerships and collaborations, and new product launches, to stay
competitive in the market. For instance, in June 2020, Cadila Pharmaceuticals
Ltd. announced the launch of Bilastine syrup (30 ml) and Bilastine tablets in
the strength of 20mg. It is an antihistamine drug that is used for the
treatment of allergic rhinitis.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
Merck & Co., Inc., Bayer AG, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Cold, Allergy, and Sinus Tablet Market is Available @ https://www.omrglobal.com/industry-reports/cold-allergy-and-sinus-tablet-market
Global Cold, Allergy and Sinus Tablet Market Report by Segment
By Type
•
Cold Tablet
•
Allergy Tablet
•
Sinus Tablet
By Application
•
Hospital
•
Clinic
•
Others
Global Cold, Allergy and Sinus Tablet Market Report by Region
Regional Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment